|
Age ≥ 65 years
|
15(53.6)
|
58(46.4)
|
0.535
|
1.3(0.6-2.8)
|
0.445
|
|
Male
|
21(75)
|
85(68)
|
0.651
|
1.4(0.6-3.3)
|
0.459
|
|
Hypertension
|
22(78.6)
|
84(67.2)
|
0.267
|
1.7(0.7-4.1)
|
0.276
|
|
Hypercholesterolemia
|
12(42.9)
|
63(50.4)
|
0.534
|
0.8(0.4-1.6)
|
0.487
|
|
Diabetes mellitus
|
10(35.7)
|
52(41.6)
|
0.672
|
0.8(0.4-1.8)
|
0.603
|
|
Smoking
|
15(53.6)
|
57(45.6)
|
0.531
|
1.3(0.6-2.8)
|
0.438
|
|
Asymptomatic ICAS
|
15(53.6)
|
59(47.2)
|
0.676
|
1.3(0.6-2.7)
|
0.514
|
|
Distributions of cerebral infarctions
| | | | | |
|
Perforating artery infarctions
|
9(32.1)
|
59(47.2)
|
0.207
|
0.6(0.3-1.3)
|
0.168
|
|
Cortical infarctions
|
16(57.1)
|
62(49.6)
|
0.534
|
1.6(0.7-3.4)
|
0.241
|
|
Internal border-zone infarctions
|
16(57.1)
|
64(51.2)
|
0.677
|
1.3(0.6-2.8)
|
0.438
|
|
NIHSS score at admission ≥ 4
|
11(39.3)
|
62(49.6)
|
0.404
|
0.9(0.4-2.0)
|
0.855
|
|
Poor MCA branch signal intensity
|
25(89.3)
|
93(74.4)
|
0.134
|
2.8(0.8-9.3)
|
0.091
|
|
Grade C
|
18(64.3)
|
42(33.6)
|
0.005
|
3.2(1.5-6.9)
|
0.003
|
|
Discontinued antiplatelet drug
|
1(3.6)
|
6(4.8)
|
1.000
|
0.5(0.1-3.6)
|
0.481
|
|
Discontinued statin
|
4(14.3)
|
13(10.4)
|
0.554
|
1.2(0.4-3.1)
|
0.759
|
